[ad_1] Pharmacists in the UK are speaking out against the rising registration fees charged by the Royal Pharmaceutical Society (RPS). The RPS is the professional body for pharmacists in England, Wales, and Scotland, and it is responsible for regulating the profession, setting standards, and providing support for its members.

Every year, the RPS charges pharmacists a fee to renew their registration with the society. This fee has been steadily increasing in recent years, with the most recent increase being a 1.9% rise to £269 for the 2021/22 registration period.

Many pharmacists are frustrated with the rising cost of registration fees, as they feel that they are not getting enough value for their money. In addition to the registration fee, many pharmacists are also required to pay for other RPS services, such as continuing professional development (CPD) courses and membership of professional networks.

Some pharmacists are also questioning the RPS’s priorities, as they argue that the society should be focusing on supporting its members rather than raising fees. There are concerns that the rising costs could deter some pharmacists from renewing their registration with the RPS, which could have negative implications for the profession as a whole.

In response to these concerns, the RPS has defended its fee increases, arguing that they are necessary to fund its services and activities. The society has also highlighted the benefits of being a member, such as access to professional networks and support for continuing professional development.

However, many pharmacists believe that the RPS needs to be more transparent about how it spends its funds and more responsive to the needs of its members. Some are calling for a review of the registration fee structure to ensure that it is fair and reasonable for all pharmacists.

Overall, the rising cost of RPS registration fees is a contentious issue that is causing concern among many pharmacists. It is clear that there needs to be a more constructive dialogue between the RPS and its members to find a solution that benefits pharmacists, the profession, and the public.[ad_2]